In a move that reaffirms its position as a powerhouse in the life sciences sector, Merck has made a resounding statement with a substantial €180 million investment to expand its distribution center in Schnelldorf, Germany. This ambitious project has nearly doubled the existing facility's size b
The biopharmaceutical industry is currently experiencing a profound transformation, as companies, both large and small, are compelled to reassess their workforce levels. This sweeping realignment is a result of several factors influencing the sector, including diminished funding opportunities, the
The recent unveiling of the Sefia manufacturing platform by Cytiva, in partnership with Gilead Sciences’ Kite Pharma, marks a transformative step in the field of CAR-T cell therapy. With demand for these life-saving treatments increasing, the traditional production methods, fraught with manual l
The winds of change are coursing through the corridors of the European Union (EU) institutions as sweeping reforms to pharmaceutical legislation are poised to redefine the biopharmaceutical playing field. Originating from the European Commission's Pharmaceutical Strategy for Europe, these
In the dynamic landscape of the stock market, few stories encapsulate the sheer unpredictability like that of Sunshine Biopharma Inc. (SBFM). From dizzying peaks to harrowing valleys, SBFM's fiscal journey over the past year reads like a thrilling financial epic. With the highest crest at
The biopharmaceutical industry is at a critical juncture, facing the pressing need to incorporate sustainability into its growth and innovation strategies. The rise of artificial intelligence (AI) presents both opportunities and challenges in this quest. While AI has demonstrated a profound ability
